Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. COCP
COCP logo

COCP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cocrystal Pharma Inc (COCP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.040
1 Day change
-0.95%
52 Week Range
2.670
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

COCP is not a good buy right now for a beginner, long-term investor with $50,000-$100,000 to deploy. The stock is trading near $1.05 with only a slight move above the prior close, while momentum is mixed and there is no strong proprietary buy signal. With no recent news, no meaningful hedge fund or insider accumulation, no valuation support, and no clear financial snapshot to justify a long-term thesis, the stock lacks a compelling case for immediate entry. Best direct conclusion: hold and avoid initiating a large long-term position at this time.

Technical Analysis

Technically, COCP is neutral to mildly constructive but not strong enough to justify a buy. MACD histogram is positive at 0.0152, but it is contracting, which weakens near-term momentum. RSI_6 is 55.106, a neutral reading with no clear overbought or oversold signal. Moving averages are converging, suggesting sideways action rather than a trending breakout. Price is sitting near pivot 1.02, with near-term resistance at 1.07 and 1.10 and support at 0.971 and 0.94. Overall trend: range-bound and undecisive.

Positive Catalysts

  • No news in the recent week means there are no immediate event-driven positives or fresh catalysts. Technical structure is near pivot support, and the one-month pattern-based projection suggests possible upside of 8.45% over the next month, but this is not strong enough on its own. There is also no major negative sentiment from hedge funds or insiders, which keeps the setup from being outright bearish.

Neutral/Negative Catalysts

  • No recent news removes near-term excitement and makes catalyst-driven gains unlikely. Hedge funds are neutral, insiders are neutral, and there is no recent congress trading data or notable institutional buying to support confidence. The technical picture is not showing a breakout, and the AI Stock Picker and SwingMax both show no signal. Financial data is unavailable, so there is no evidence of improving fundamentals to support a long-term purchase.

Financial Performance

Financial snapshot data was unavailable due to an error, so latest-quarter revenue, earnings, and growth trends could not be confirmed. Because the latest quarter season is not provided, there is no reliable financial evidence to support a long-term buying decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible trend in Wall Street sentiment. Based on the available data, pros are limited to neutral positioning and a mildly positive technical MACD, while cons include lack of news, no strong buying signals, no valuation support, and no financial snapshot. Overall Wall Street view cannot be confirmed as bullish from the available information.

Wall Street analysts forecast COCP stock price to rise
1 Analyst Rating
Wall Street analysts forecast COCP stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.050
sliders
Low
10
Averages
10
High
10
Current: 1.050
sliders
Low
10
Averages
10
High
10
No data

No data

People Also Watch